Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 1
42
Views
0
CrossRef citations to date
0
Altmetric
Clinician’s Corner

Native mitral valve endocarditis due to Corynebacterium striatum, an uncommon pathogen

, BAORCID Icon, , PA-C & , MD, MSORCID Icon
Pages 151-153 | Received 27 Feb 2023, Accepted 10 Sep 2023, Published online: 09 Oct 2023

  • Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882–893. doi:10.1016/S0140-6736(15)00067-7.
  • Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638. doi:10.1086/313753.
  • Østergaard L, Voldstedlund M, Bruun NE, et al. Temporal changes, patient characteristics, and mortality, according to microbiological cause of infective endocarditis: a nationwide study. J Am Heart Assoc. 2022;11(16):e025801. doi:10.1161/JAHA.122.025801.
  • Cabanilla MG, Jones E, Norville SV, Santana A. A case series of Corynebacterium striatum native valve infective endocarditis. J Cardiol Cases. 2022;26(3):194–196. doi:10.1016/j.jccase.2022.04.014.
  • Belmares J, Detterline S, Pak JB, Parada JP. Corynebacterium endocarditis species-specific risk factors and outcomes. BMC Infect Dis. 2007;7:4. doi:10.1186/1471-2334-7-4.
  • Chen FL, Hsueh PR, Teng SO, Ou TY, Lee WS. Corynebacterium striatum bacteremia associated with central venous catheter infection. J Microbiol Immunol Infection. 2012;45(3):255–258. doi:10.1016/j.jmii.2011.09.016.
  • McMullen AR, Anderson N, Wallace MA, Shupe A, Burnham CA. When good bugs go bad: epidemiology and antimicrobial resistance profiles of Corynebacterium striatum, an emerging multidrug-resistant, opportunistic pathogen. Antimicrob Agents Chemother. 2017;61(11):e01111–17. doi:10.1128/AAC.01111-17.
  • Biscarini S, Colaneri M, Mariani B, Pieri TC, Bruno R, Seminari E. A case of Corynebacterium striatum endocarditis successfully treated with an early switch to oral antimicrobial therapy. Infezioni Medicina. 2021;1:138–144.
  • Silva-Santana G, Silva CMF, Olivella JGB, Silva IF, Fernandes LMO, Sued-Karam BR, Santos CS, Souza C, Mattos-Guaraldi AL. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976-2020. Arch Microbiol. 2021;203(5):1863–1880. doi:10.1007/s00203-021-02246-1.
  • Hahn WO, Werth BJ, Butler-Wu SM, et al. Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs. Emerging Infect Dis. 2016;22(11):1908–1914. doi:10.3201/eid2211.160141.
  • Milosavljevic MN, Milosavljevic JZ, Kocovic AG, et al. Antimicrobial treatment of Corynebacterium striatum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2021;63:e49. doi:10.1590/S1678-9946202163049.
  • Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis. 2002;34(5):695–698. doi:10.1086/338403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.